Enhanced expression of γ-glutamylcysteine synthetase and glutathione S- transferase genes in cisplatin-resistant bladder cancer cells with multidrug resistance phenotype

Journal of Urology

Volumn 157, Issue 3, 1997, Pages 1054-1058

  Kotoh, Shuji ^a   Naito, Seiji ^a   Yokomizo, Akira ^a   Kohno, Kimitoshi ^a   Kuwano, Michihiko ^a   Kumazawa, Joichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

bladder cancer; cisplatin; glutathione 5 transferase; multidrug resistance; glutamylcysteine synthetase

Indexed keywords

CISPLATIN; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE TRANSFERASE;

ARTICLE; BLADDER CANCER; CONFORMATIONAL TRANSITION; DNA CONFORMATION; DRUG ACCUMULATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL;

EID: 0031013186     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65140-1     Document Type: Article

References (25)

1. Sternberg, C. N., Yagoda, A., Scher, H. I., Watson, R. C., Herr, H. W., Morse, M. J., Sogani, P. C., Vaughan, E. D., Jr., Bander, N., Weiselberg, L. R., Geller, N., Hollander, P. S., Lipperman, R., Fair, W. R. and Whitmore, W. F., Jr.: M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J. Urol., 139: 461, 1988.
2. Godwin, A. K., Meister, A., O'Dwyer, P. J., Huang, C. S., Hamilton, T. C. and Anderson, M. E.: High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad. Sci., 89: 3070, 1992.
3. Saburi, Y., Nakagawa, M., Ono, M., Sakai, M., Muramatsu, M., Kohno, K. and Kuwano, M.: Increased expression of glutathione S-transferase gene in cis-diamminedichloroplatinum(II)-resistant variants of a Chinese hamster ovary cell line. Cancer Res., 49: 7020, 1989.
4. Andrews, P. A., Velury, S., Mann, S. C. and Howell, S. B.: cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res., 48: 68, 1988.
5. Masuda, H., Ozols, R. F., Lai, G. M., Fojo, A., Rothenberg, M. and Hamilton, T. C.: Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum(II) in human ovarian cancer cell lines. Cancer Res., 48: 5713, 1988.
6. Kotoh, S., Naito, S., Yokomizo, A., Kumazawa, J., Asakuno, K., Kohno, K. and Kuwano, M.: Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells. Cancer Res., 54: 3248, 1994.
7. Taya, T., Kobayashi, T., Tsukahara, K., Uchibayashi, T., Naito, K., Hisazumi, H. and Kuroda, K.: In vitro culture of malignant tumor tissue from the human urinary tract. Jpn. J. Urol., 68: 1003, 1977.
8. Sargent, J. M. and Taylor, C. G.: Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukemia. Br. J. Cancer, 60: 206, 1989.
9. Maehara, Y., Kusumoto, T., Kusumoto, H., Anai, H. and Sugimachi, K.: Sodium succinate enhances the colorimetric reaction of the in vitro chemosensitivity test: MTT assay. Oncology, 45: 434, 1988.
10. Bradford, M. N.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem., 72: 248, 1976.
11. Griffith, O. W.: Determination of glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem., 106: 207, 1980.
12. Habig, W. H., Pabst, M. J. and Jakoby, W. B.: Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem., 249: 7130, 1974.
13. Matsuo, K., Kohno, K., Takano, H., Sato, S., Kiue, A. and Kuwano, M.: Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines. Cancer Res., 50: 5819, 1990.
14. Kano, T., Sakai, M. and Muramatsu, M.: Structure and expression of a human class p glutathione S-transferase messenger RNA. Cancer Res., 47: 5626, 1987.
15. Gipp, J. J., Chang, C. and Mulcahy, T.: Cloning and nucleotide sequence of a full-length cDNA for human liver γ-glutamylcysteine synthetase. Biochem. Biophys. Res. Commun., 185: 29, 1992.
16. Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V. and Deeley, R. G.: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258: 1650, 1992.
17. Tso, J. Y., Sun, X. H., Kao, T. H., Reece, K. S. and Wu, R.: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res., 13: 2485, 1985.
18. Eastman, A.: Mechanisms of resistance to cisplatin. In: Molecular and Clinical Advances in Anticancer Drug Resistance. Edited by R. F. Ozols. Boston: Kluwer Academic Publishers, pp. 233-249, 1991.
19. Ishikawa, T., Wright, C. D. and Ishizuka, H.: GS-X pump is functionally overexpressed in cis-diamminedichloroplatinum(II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. J. Biol. Chem., 269: 29085, 1994.
20. Takano, H., Kohno, K., Matsuo, K., Matsuda, T. and Kuwano, M.: DNA topoisomerase-targeting antitumor agents and drug resistance. Anti-Cancer Drugs, 3: 323, 1992.
21. Eder, J. P. J., Chan, V. T.-W., Niemierko, E., Teicher, B. A. and Schnipper, L. E.: Conditional expression of wild-type topoisomerase II complements a mutant enzyme in mammalian cells. J. Biol. Chem., 268: 13844, 1993.
22. Meijer, C., Mulder, N. H. and De Vries, E. G. E.: The role of detoxifying systems in resistance of tumor cells to cisplatin and adriamycin. Cancer Treatment Reviews, 17: 389, 1990.
23. Teicher, B. A., Holden, S. A., Herman, T. S., Sotomayor, E. A., Khandekar, V., Rosbe, K. W., Brann, T. W., Korbut, T. T. and Frei, E., III: Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II). Int. J. Cancer, 47: 252, 1991.
24. Nakagawa, M., Nomura, Y., Kohno, K., Ono, M., Mizoguchi, H., Ogata, J. and Kuwano, M.: Reduction of drug accumulation in cisplatin-resistant variants of human prostatic cancer PC-3 cell line. J. Urol., 150: 1970, 1993.
25. Awasthi, S., Singhal, S. S., Srivastava, S. K., Zimniak, P., Bajpai, K. K., Saxena, M., Sharma, R., Ziller, S. A., III, Frenkel, E. P., Singh, S. V., He, N. G. and Awasthi, Y. C.: Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the p-glycoprotein. J. Clin. Invest., 93: 958, 1994.